CINGW Cingulate Inc. - Warrants
NASDAQ · Auf SEC EDGAR ansehen ↗ Schließen Sep 30, 2026 10-K/10-Q Aug 13, 2026
$0,01
· % der 52-Wochen-Spanne
· über Tiefststand
· zu hoch
$0,0152-Wochen-Tief
$0,0652-Wochen-Hoch
Marktkapitalisierung (MRQ)
$70.9K
EPS
$-4.44
Ihre Abzeichen
52W-Spanne
$0–$0
Analystenbewertung
·
Kursziel
·
P/E
·
ROE
-559.8%
Nettogewinnmarge
1649.4%
Ihre Abzeichenleiste ist leer – heften Sie eine Kennzahl auf dieser Seite an.
CINGW Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$0.01
Marktkapitalisierung (MRQ)
$70.9K
EPS
$-4.44
ROE
-559.8%
Verschuldungsgrad (MRQ)
0.2
52W-Spanne
$0–$0
CINGW Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Spanne
Balken
Die Balkengranularität passt sich der ausgewählten Periode an – bewegen Sie den Mauszeiger über das Diagramm, um Eröffnungs-/Höchst-/Tiefst-/Schlusskurse für einen Balken anzuzeigen.
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
EPS$-4.442022-12-31 → 2025-12-31
Freier Cashflow$-17M2021-12-31 → 2025-12-31
Nettogewinnmarge1649.4%2025-12-31 → 2025-12-31
Bewertung & Kennzahlen
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
| Kennzahl | 5-Jahres-Trend | CINGW | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| K/B (MRQ) | 0.0 | · | · | · |
Der Median der Vergleichsgruppe wird pro Kennzahl standardisiert berechnet und stimmt möglicherweise nicht immer mit der für diese Aktie angezeigten TTM/MRQ-Basis überein.
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
| Kennzahl | 5-Jahres-Trend | CINGW | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Operating Margin (Betriebsgewinnmarge) | 1464.8% | · | · | · | |
| EBITDA Margin (EBITDA-Marge) | 1464.8% | · | · | · | |
| Pretax Margin (Vorgewinnmarge) | 1649.4% | · | · | · | |
| Net Profit Margin (Nettogewinnmarge) | 1649.4% | · | · | · | |
| ROA | -150.0%5-Jahres-Durchschnitt ≈-176.6% | ≈-176.6% | · | · | |
| ROE | -559.8%5-Jahres-Durchschnitt ≈-101.1% | ≈-101.1% | · | · |
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
| Kennzahl | 5-Jahres-Trend | CINGW | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Fremdkapital / Eigenkapital (MRQ) | 0.25-Jahres-Durchschnitt ≈0.9 | ≈0.9 | · | · | |
| Liquiditätsgrad (MRQ) | 3.55-Jahres-Durchschnitt ≈4.2 | ≈4.2 | · | · | |
| Quick Ratio | 1.15-Jahres-Durchschnitt ≈3.7 | ≈3.7 | · | · |
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
Für diese Kennzahlengruppe sind noch keine Daten verfügbar
Noch nicht genügend Fundamentaldaten vorhanden, um diese Kennzahlengruppe zu berechnen.
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
| Kennzahl | 5-Jahres-Trend | CINGW | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Asset Turnover (Umsatz / Vermögenswerte) | -0.1 | · | · | · |
Wert · ≈ 5-Jahres-Durchschnitt · Branchenmedian · Urteil relativ zum Median
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| R&D Expense | $10M | $9M | $15M | $9M | $8M | $5M | |
| SG&A Expense | $10M | $6M | $7M | $9M | $12M | $2M | |
| Operating Income | $-20M | $-16M | $-23M | $-18M | $-21M | $-7M | |
| Interest Expense | · | · | $790.0K | $292.3K | · | · | |
| Other Non-op | · | $99.2K | $-775.8K | $-174.5K | $-30.6K | $-100.3K | |
| Pretax Income | $-22M | $-17M | $-24M | $-18M | $-21M | $-7M | |
| Net Income | $-22M | $-17M | $-24M | $-18M | $-21M | $-7M | |
| EPS (Basic) | $-4.44 | $-10.86 | $-311.99 | $-29.35 | $-2.79 | · | |
| EPS (Diluted) | $-4.44 | $-10.86 | $-311.99 | $-29.35 | · | · | |
| Shares (Basic) | 5,055,329 | 1,524,797 | 75,435 | 602,340 | 7,413,579 | · | |
| Shares (Diluted) | 5,055,329 | 1,524,797 | 75,435 | 602,340 | · | · | |
| EBITDA | $-20M | $-16M | $-23M | $-18M | $-21M | · |
Bilanz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $11M | $12M | $52.4K | $5M | $16M | $1M | |
| Short-term Investments | · | · | · | · | $933 | $933 | |
| Receivables | · | · | $14.6K | · | · | · | |
| Prepaid Expense | $1M | $423.2K | $511.6K | $2M | $2M | $439.5K | |
| Current Assets | $12M | $13M | $578.6K | $8M | $19M | $2M | |
| PP&E (Net) | $2M | $2M | $3M | $3M | $3M | $3M | |
| PP&E (Gross) | $6M | $5M | $5M | $5M | $5M | $4M | |
| Accum. Depreciation | $4M | $3M | $3M | $2M | $2M | $957.7K | |
| Total Assets | $15M | $15M | $3M | $11M | $23M | $6M | |
| Accounts Payable | $2M | $1M | $5M | $762.4K | $264.7K | $975.1K | |
| Accrued Liabilities | $2M | $1M | $2M | $894.6K | $601.3K | $1M | |
| Short-term Debt | $6M | $3M | $3M | $5M | · | $500.3K | |
| Current Liabilities | $10M | $5M | $10M | $7M | $1M | $3M | |
| Capital Leases | $1M | · | $130.7K | $488.7K | $828.5K | $1M | |
| Other Non-current Liabilities | · | · | · | · | · | $23.6K | |
| Total Liabilities | $13M | $7M | $10M | $8M | $2M | $4M | |
| Total Debt | $6M | $3M | $3M | $5M | · | · | |
| Common Stock | $725 | $340 | $10 | $61 | $1.1K | · | |
| Paid-in Capital | $135M | $117M | $86M | $73M | $73M | · | |
| Retained Earnings | $-132M | $-110M | $-93M | $-69M | $-52M | $-31M | |
| AOCI | · | · | · | · | $165 | $165 | |
| Stockholders' Equity | $3M | $7M | $-7M | $4M | $21M | $1M | |
| Liabilities + Equity | $15M | $15M | $3M | $11M | $23M | $6M | |
| Shares Outstanding | 7,250,299 | 3,402,306 | 97,293 | 602,640 | 11,309,412 | · |
Cashflow
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Stock-based Comp | $2M | $995.5K | $812.7K | $800.8K | $43.8K | · | |
| Deferred Tax | · | · | · | $0 | $0 | · | |
| Operating Cash Flow | $-17M | $-18M | $-15M | $-16M | $-10M | $-7M | |
| CapEx | $162.1K | $211.8K | $224.1K | $153.4K | $814.7K | $402.1K | |
| Investing Cash Flow | $-162.1K | $-211.8K | $-224.1K | $-152.7K | $-814.7K | $-384.2K | |
| Stock Issued | $10M | $26M | $7M | · | $20M | · | |
| Net Stock Activity | $10M | $26M | $7M | · | $20M | · | |
| Financing Cash Flow | $16M | $31M | $10M | $5M | $27M | $8M | |
| Net Change in Cash | $-1M | $12M | $-5M | $-11M | $15M | · | |
| Free Cash Flow | $-17M | $-19M | $-15M | $-16M | $-11M | · |
Rentabilität
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Operating Margin | 1464.8% | · | · | · | · | · | |
| Net Margin | 1649.4% | · | · | · | · | · | |
| Pretax Margin | 1649.4% | · | · | · | · | · | |
| EBITDA Margin | 1464.8% | · | · | · | · | · | |
| ROA | -150.0% | -169.4% | -316.0% | -103.1% | -144.4% | · | |
| ROE | -559.8% | -159.5% | 675.7% | -288.6% | -173.1% | · |
Liquidität & Solvenz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 1.2 | 2.5 | 0.1 | 1.1 | 16.0 | · | |
| Quick Ratio | 1.1 | 2.5 | 0.0 | 0.8 | 14.0 | · | |
| Debt / Equity | 2.5 | 0.3 | -0.4 | 1.3 | · | · | |
| Interest Coverage | · | · | -28.8 | -59.9 | · | · |
Effizienz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Asset Turnover | -0.1 | · | · | · | · | · |
Pro Aktie
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.35 | $2.19 | $-5.88 | $0.34 | $1.84 | · | |
| Revenue / Share | $-0.27 | · | · | · | · | · | |
| Cash Flow / Share | $-3.41 | $-12.10 | $-16.61 | · | · | · | |
| Cash / Share | $1.51 | $3.59 | $0.04 | $0.47 | $1.46 | · | |
| EPS (TTM) | $-4.44 | $-10.86 | $-311.99 | $-29.35 | · | · |
Bewertung (TTM)
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue TTM | $-1M | $99.2K | · | · | · | · | |
| Net Income TTM | $-22M | $-17M | $-24M | $-18M | $-21M | · |
Gewinn- und Verlustrechnung
| Kennzahl | Trend | Q2 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $1M | $2M | $3M | $3M | $2M | $4M | $1M | $2M | $2M | $5M | $4M | $4M | $2M | $2M | $2M | $2M | |
| SG&A Expense | $4M | $4M | $3M | $2M | $1M | $2M | $2M | $1M | $1M | $2M | $2M | $2M | $2M | $3M | $2M | $2M | |
| Operating Income | $-5M | $-6M | $-6M | $-5M | $-4M | $-6M | $-3M | $-3M | $-3M | $-7M | $-6M | $-6M | $-4M | $-4M | $-4M | $-4M | |
| Interest Expense | · | · | · | · | · | · | · | · | $31.2K | · | $237.5K | $252.5K | $187.5K | $187.5K | $104.8K | · | |
| Interest Income | · | · | · | $93.0K | · | · | · | $2.2K | · | · | · | · | · | · | · | · | |
| Other Non-op | · | · | $-573.1K | $-138.8K | $-96.7K | · | $50.5K | $-3.5K | $-24.3K | $-137.5K | $-229.4K | $-253.9K | $-154.9K | $-129.8K | $-58.9K | $8.4K | |
| Pretax Income | $-6M | $-7M | $-7M | $-5M | $-4M | $-6M | $-4M | $-3M | $-3M | $-7M | $-6M | $-7M | $-4M | $-5M | $-4M | $-4M | |
| Net Income | $-6M | $-6M | $-7M | $-5M | $-4M | $-6M | $-4M | $-3M | $-3M | $-7M | $-6M | $-7M | $-4M | $-5M | $-4M | $-4M | |
| EPS (Basic) | $-0.45 | $-0.96 | $-1.35 | $-1.14 | $-1.04 | $4.16 | $-2.34 | $-5.47 | $-7.21 | $-231.74 | $-72.60 | $-0.57 | $-7.08 | $-28.19 | $-0.36 | $-0.36 | |
| EPS (Diluted) | $-0.45 | $-0.96 | $-1.35 | $-1.14 | $-1.04 | $4.16 | $-2.34 | $-5.47 | $-7.21 | $-225.52 | $-72.60 | $-6.79 | $-7.08 | $-28.19 | $-0.36 | $-0.36 | |
| Shares (Basic) | 13,186,057 | · | 5,431,206 | 4,389,465 | 3,646,893 | · | 1,766,362 | 586,313 | 412,126 | · | 82,361 | 11,694,823 | 565,471 | · | 11,309,412 | 11,309,412 | |
| Shares (Diluted) | 13,186,057 | · | 5,431,206 | 4,389,465 | 3,646,893 | · | 1,766,362 | 586,313 | 412,126 | · | 82,361 | 974,569 | 565,471 | · | 11,309,412 | 11,309,412 | |
| EBITDA | $-5M | · | $-6M | $-5M | $-4M | · | $-3M | $-3M | $-3M | · | $-6M | $-6M | $-4M | · | $-4M | $-4M |
Bilanz
| Kennzahl | Trend | Q2 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $28M | $11M | $6M | $9M | $10M | $12M | $10M | $380.9K | $1M | $52.4K | $2M | $349.8K | $2M | $5M | $10M | $8M | |
| Receivables | · | · | · | · | · | · | $2.2K | $2M | · | · | · | · | · | · | · | · | |
| Prepaid Expense | $2M | $1M | $1M | $1M | $944.4K | $423.2K | $1M | $518.2K | $2M | $511.6K | $910.3K | $2M | $2M | $2M | $2M | $2M | |
| Current Assets | $30M | $12M | $7M | $10M | $11M | $13M | $11M | $3M | $3M | $578.6K | $3M | $2M | $4M | $8M | $12M | $10M | |
| PP&E (Net) | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | |
| PP&E (Gross) | $6M | $6M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | |
| Accum. Depreciation | $4M | $4M | $4M | $4M | $3M | $3M | $3M | $3M | $3M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Total Assets | $33M | $15M | $11M | $13M | $12M | $15M | $14M | $5M | $5M | $3M | $6M | $5M | $7M | $11M | $15M | $14M | |
| Accounts Payable | $2M | $2M | $866.2K | $872.9K | $855.1K | $1M | $906.2K | $1M | $737.9K | $5M | $2M | $2M | $599.0K | $762.4K | $392.8K | $282.3K | |
| Accrued Liabilities | $1M | $2M | $2M | $501.8K | $601.8K | $1M | $402.2K | $383.3K | $1M | $2M | $692.0K | $1M | $699.2K | $894.6K | $670.7K | $311.6K | |
| Short-term Debt | $5M | $6M | $3M | $5M | $4M | $3M | · | · | · | $3M | $3M | $8M | $5M | $5M | $5M | · | |
| Current Liabilities | $9M | $10M | $6M | $7M | $6M | $5M | $2M | $2M | $2M | $10M | $6M | $11M | $7M | $7M | $6M | $923.5K | |
| Capital Leases | $968.5K | $1M | $1M | $1M | · | · | · | · | $33.1K | $130.7K | $225.4K | $317.3K | $405.5K | $488.7K | $578.6K | $665.8K | |
| Total Liabilities | $10M | $13M | $7M | $8M | $7M | $7M | $2M | $2M | $2M | $10M | $6M | $11M | $7M | $8M | $7M | $2M | |
| Total Debt | $5M | · | $3M | $5M | $4M | · | · | · | · | · | $3M | $8M | $5M | · | $5M | · | |
| Common Stock | $1.4K | $725 | $596 | $488 | $382 | $340 | $305 | $78 | $502 | $10 | $1.7K | $1.2K | $1.1K | $61 | $1.1K | $1.1K | |
| Paid-in Capital | $171M | $135M | $130M | $123M | $118M | $117M | $114M | $102M | $99M | $86M | $86M | $74M | $73M | $73M | $73M | $73M | |
| Retained Earnings | $-148M | $-132M | $-126M | $-117M | $-112M | $-110M | $-102M | $-99M | $-96M | $-93M | $-86M | $-80M | $-73M | $-69M | $-65M | $-61M | |
| AOCI | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $-3.2K | |
| Stockholders' Equity | $23M | $3M | $3M | $6M | $6M | $7M | $12M | $3M | $3M | $-7M | $-96.3K | $-6M | $81.6K | $4M | $8M | $12M | |
| Liabilities + Equity | $33M | $15M | $11M | $13M | $12M | $15M | $14M | $5M | $5M | $3M | $6M | $5M | $7M | $11M | $15M | $14M | |
| Shares Outstanding | 13,894,882 | 7,250,299 | 5,977,358 | 4,889,290 | 3,826,199 | 3,402,306 | 3,044,165 | 780,762 | 5,010,470 | 97,293 | 17,378,798 | 12,056,788 | 11,309,412 | 602,640 | 11,309,412 | 11,309,412 |
Cashflow
| Kennzahl | Trend | Q2 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $362.2K | $386.0K | $592.8K | $187.4K | $357.6K | $60.3K | $393.8K | $376.8K | $164.6K | $154.6K | $236.3K | $217.4K | $204.5K | $206.4K | $205.7K | $207.2K | |
| Deferred Tax | · | · | · | · | · | · | · | · | · | · | · | · | $0 | · | $0 | $0 | |
| Operating Cash Flow | $-6M | $-4M | $-4M | $-5M | $-5M | $-4M | $-4M | $-2M | $-9M | $-3M | $-4M | $-5M | $-4M | $-4M | $-3M | $-4M | |
| CapEx | $67.1K | $156.2K | $0 | · | · | $198.5K | $-140.8K | $72.6K | $81.5K | $187.0K | $0 | $1 | $37.1K | $143.0K | $0 | $0 | |
| Investing Cash Flow | $-67.1K | $-156.2K | $0 | · | · | $-198.5K | $140.8K | $-72.6K | $-81.5K | $-187.0K | $0 | $-1 | $-37.1K | $-143.0K | $3.2K | $-2.5K | |
| Stock Issued | $9M | $3M | $1M | $4M | $2M | $1M | $13M | $1M | $10M | $819.5K | $6M | · | · | · | · | · | |
| Net Stock Activity | · | · | · | · | $2M | · | · | · | $10M | · | · | · | · | · | · | · | |
| Financing Cash Flow | $8M | $9M | $1M | $4M | $2M | $6M | $13M | $1M | $10M | $815.4K | $6M | $3M | $-3.9K | $-89.8K | $5M | $-3.7K | |
| Net Change in Cash | $3M | $5M | $-3M | $-618.8K | $-3M | $2M | $10M | $-732.9K | $1M | $-2M | $2M | $-1M | $-4M | $-4M | $2M | $-4M | |
| Free Cash Flow | · | · | · | · | · | · | · | · | $-9M | · | · | · | $-4M | · | · | · |
Rentabilität
| Kennzahl | Trend | Q2 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 3909.4% | · | · | 3395.9% | 3829.2% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Margin | 4238.1% | · | · | 3497.2% | 3929.1% | · | · | · | · | · | · | · | · | · | · | · | |
| Pretax Margin | 4238.1% | · | · | 3497.2% | 3929.1% | · | · | · | · | · | · | · | · | · | · | · | |
| EBITDA Margin | 3909.4% | · | · | 3395.9% | 3829.2% | · | · | · | · | · | · | · | · | · | · | · | |
| ROA | -25.2% | · | -60.9% | -51.5% | -42.3% | · | -33.2% | -62.0% | -47.0% | · | -56.3% | -69.5% | -31.3% | · | -52.4% | -58.5% | |
| ROE | -40.5% | · | -94.7% | -111.4% | -83.2% | · | -54.1% | 212.9% | -180.3% | · | -144.6% | -217.4% | -49.8% | · | -96.3% | -66.3% |
Liquidität & Solvenz
| Kennzahl | Trend | Q2 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.5 | · | 1.3 | 1.5 | 1.9 | · | 7.4 | 1.2 | 1.2 | · | 0.5 | 0.2 | 0.6 | · | 1.8 | 10.9 | |
| Quick Ratio | 3.3 | · | 1.0 | 1.3 | 1.7 | · | 6.5 | 1.0 | 0.5 | · | 0.3 | 0.0 | 0.3 | · | 1.5 | 8.9 | |
| Debt / Equity | 0.2 | · | 0.9 | 0.9 | 0.7 | · | · | · | · | · | -31.1 | -1.3 | 61.3 | · | 0.6 | · | |
| Interest Coverage | · | · | · | · | · | · | · | · | -94.3 | · | -24.2 | -25.2 | -20.5 | · | -37.9 | · |
Effizienz
| Kennzahl | Trend | Q2 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | -0.0 | · | · | -0.0 | -0.0 | · | · | · | · | · | · | · | · | · | · | · |
Pro Aktie
| Kennzahl | Trend | Q2 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $1.69 | · | $0.58 | $1.13 | $1.55 | · | $3.95 | $3.95 | $0.64 | · | $-0.01 | $-0.51 | $0.01 | · | $0.74 | $1.08 | |
| Revenue / Share | $-0.01 | · | · | $-0.03 | $-0.03 | · | · | · | · | · | · | · | · | · | · | · | |
| Cash Flow / Share | · | · | · | · | $-1.26 | · | · | · | $-1.77 | · | · | · | · | · | · | · | |
| Cash / Share | $2.04 | · | $1.02 | $1.82 | $2.49 | · | $3.30 | $0.49 | $0.22 | · | $0.11 | $0.03 | $0.15 | · | $0.87 | $0.72 | |
| EPS (TTM) | $-3.71 | · | $0.61 | $-0.38 | $-4.71 | · | $-240.54 | $-310.80 | $-312.12 | · | $-114.66 | $-42.42 | $-35.99 | · | · | · |
Bewertung (TTM)
| Kennzahl | Trend | Q2 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-29M | · | $-22M | $-19M | $-17M | · | $-17M | $-19M | $-23M | · | $-21M | $-19M | $-17M | · | $-16M | $-27M | |
| Market Cap | $835.1K | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Enterprise Value | $-23M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| P/E | -0.0 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| P/B | 0.0 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| P / Tangible Book | 0.0 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Earnings Yield | -6173.0% | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · |
Aktuellster Zeitraum links · fehlende Werte werden als · angezeigt
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Betriebsgewinnmarge % | 1464.8% | · | · | · | · |
| Nettoergebnis | $-22M | $-17M | $-24M | $-18M | $-21M |
| Verwässerte EPS | $-4.44 | $-10.86 | $-311.99 | $-29.35 | · |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Fremdkapital / Eigenkapital | 2.5 | 0.3 | -0.4 | 1.3 | · |
| Liquiditätsgrad | 1.2 | 2.5 | 0.1 | 1.1 | 16.0 |
| Quick Ratio | 1.1 | 2.5 | 0.0 | 0.8 | 14.0 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Freier Cashflow | $-17M | $-19M | $-15M | $-16M | $-11M |
Institutionelle Eigentümer (13F) 8 Einreicher · $2K gesamt · Stand 30. September 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Inhaber
8
Gehaltener Wert
$2K
Neue Positionen
6
Geschlossene Positionen
2
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 6 (+4 vs. Vorquartal) | 2 (+1 vs. Vorquartal) | 1 (+1 vs. Vorquartal) | 0 (-1 vs. Vorquartal) | +94K |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| CAPTRUST FINANCIAL ADVISORS | $672 | 35.200 | 36,60% | Aktien |
| MAI Capital Management | $497 | 26.021 | 27,07% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $441 | 23.080 | 24,02% | Aktien |
| TWO SIGMA SECURITIES, LLC | $209 | 10.918 | 11,38% | Aktien |
| GoalVest Advisory LLC | $15 | 3.000 | 0,82% | Aktien |
| TORONTO DOMINION BANK | $2 | 100 | 0,11% | Aktien |
| HRT FINANCIAL LP | $0 | 13.224 | 0,00% | Aktien |
| Virtu Financial LLC | $0 | 12.626 | 0,00% | Aktien |
Unternehmensinsider 12 Insider · 7 Führungskräfte · 6 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Shane J. Schaffer | Chief Executive Officer | 16. Juli 2026 A | · | 0 | 0 | $0 |
| Jennifer L. Callahan | EVP and CFO | 16. Juli 2026 A | · | 0 | 0 | $0 |
| Laurie Myers | EVP and COO | 7. Juli 2025 A | · | 0 | 0 | $0 |
| Raul R. Silva | EVP and CSO | 30. September 2026 A | · | 0 | 0 | $0 |
| Bryan Wade Downey | EVP & Chief Commercial Officer | 16. Juli 2026 A | · | 0 | 0 | $0 |
| Matthew Brams | EVP and Chief Medical Officer | 16. Juli 2026 A | · | 0 | 0 | $0 |
| Nilay Dahyabhai Patel | CLO and CCO | 8. Juli 2025 A | · | 0 | 0 | $0 |
| Bryan Jay Lawrence | Direktor | 16. Juli 2026 A | · | 0 | 0 | $0 |
| Peter J. Werth | Direktor | 16. Juli 2026 A | · | 0 | 0 | $0 |
| Thomas Jeffrey Hargroves | Direktor | 16. Juli 2026 A | · | 0 | 0 | $0 |
| Jeffrey S Ervin | Direktor | 20. Juni 2025 A | · | 0 | 0 | $0 |
| John A Roberts | Direktor | 20. Juni 2025 A | · | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das + neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Quelle: SEC 10-Q eingereicht Aug 13, 2026